Status:
NOT_YET_RECRUITING
Cross-linked and Non-cross-linked Hyaluronic Acid in Subdeltoid Bursitis
Lead Sponsor:
Taipei Medical University
Conditions:
Subdeltoid Bursitis
Hyaluronic Acid
Eligibility:
All Genders
20-80 years
Phase:
PHASE4
Brief Summary
This study aims to compare the efficacy of different structures of hyaluronic acid, namely cross-linked and non-cross-linked hyaluronic acid, in treating subdeltoid bursitis.
Detailed Description
A double-blind, randomized clinical trial will be conducted to collect 52 patients with subdeltoid bursitis. The patients will be injected with cross-linked or non-cross-linked hyaluronic acid under u...
Eligibility Criteria
Inclusion
- clinical diagnosis of subdeltoid bursitis
- age 20 or older 20
- at least one positive in the painful arc, neer test, or Hawkins test
- can attend three months of intervention and follow-up
Exclusion
- history of malignancy
- previous shoulder operation or injury
- previous shoulder injections in the past three months
Key Trial Info
Start Date :
July 25 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT06508125
Start Date
July 25 2024
End Date
December 31 2024
Last Update
July 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shin Kong Wu Ho-Su Memorial Hospital
Taipei, Taiwan, 111-01